BCL2 and ovarian cancer: CCAT1 is an upregulated lncRNA in cisplatin-resistant ovarian cancer cells; CCAT1 knockdown stimulates apoptosis, downregulates BCL-2, and upregulates BAX in ovarian cancer cells via the CCAT1/miR-454 axis (Wang et al., 2020[129]).